Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study

Authors

Corinne Jamoul (ORCID: https://orcid.org/0009-0002-9363-6077)
Alessandra Oortwijn (ORCID: https://orcid.org/0000-0002-8556-1004)
Toshifumi Hibi∥ (ORCID: https://orcid.org/0000-0002-6256-1204)
Tadakazu Hisamatsu (ORCID: https://orcid.org/0000-0002-1178-3536)
Laurent Peyrin‐Biroulet (ORCID: https://orcid.org/0000-0003-2536-6618)
Brian G. Feagan (ORCID: https://orcid.org/0000-0002-6914-3822)
Édouard Louis (ORCID: https://orcid.org/0000-0002-1287-7075)
Louis Dron (ORCID: https://orcid.org/0000-0002-3276-3948)
Haridarshan Patel (ORCID: https://orcid.org/0000-0002-1827-5163)
Virginia Taliadouros
Kristina Harris
Stefan Schreiber (ORCID: https://orcid.org/0000-0002-6807-9822)

Institutions

Western University (CA)
Inserm (FR)
Kyorin University (JP)
McGill University Health Centre (CA)
Centre Hospitalier Régional et Universitaire de Nancy (FR)
University Hospital Schleswig-Holstein (DE)
Galapagos (Netherlands) (NL)
Clinique Hartmann (FR)
Kitasato Institute Hospital (JP)
Nutrition-Génétique et Exposition aux Risques Environnementaux (FR)
Kitasato University (JP)
Galapagos (Belgium) (BE)
Université de Lorraine (FR)
University of Lübeck (DE)

Publication Details

Journal: United European Gastroenterology Journal
Published: 2024-10-25
DOI: https://doi.org/10.1002/ueg2.12686
Citations: 5
Primary Topic: Inflammatory Bowel Disease
Type: article
Field-Weighted Citation Impact: 2.75

Funders

Gilead Sciences
Galápagos

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study

Corinne Jamoul, Alessandra Oortwijn, Toshifumi Hibi∥, Tadakazu Hisamatsu et al.

Oct 25, 2024

5 citations

United European Gastroenterology Journal

Inflammatory Bowel Disease

2.75

article

Distinct trajectories of symptomatic response in ulcerative colitis during filgotinib therapy: A post hoc analysis from the SELECTION study

Corinne Jamoul, Alessandra Oortwijn, Toshifumi Hibi∥, Tadakazu Hisamatsu, Laurent Peyrin‐Biroulet, Brian G. Feagan, Édouard Louis, Louis Dron, Haridarshan Patel, Virginia Taliadouros, Kristina Harris, Stefan Schreiber

October 25, 2024article en

5 citations

Abstract

No abstract available for this paper.

United European Gastroenterology JournalVol. 12(9)

Western University (CA), Inserm (FR), Kyorin University (JP), McGill University Health Centre (CA), Centre Hospitalier Régional et Universitaire de Nancy (FR), University Hospital Schleswig-Holstein (DE), Galapagos (Netherlands) (NL), Clinique Hartmann (FR), Kitasato Institute Hospital (JP), Nutrition-Génétique et Exposition aux Risques Environnementaux (FR), Kitasato University (JP), Galapagos (Belgium) (BE), Université de Lorraine (FR), University of Lübeck (DE)

Gilead Sciences, Galápagos

Good health and well-being

Openalex Percentile: Top 9%

Inflammatory Bowel Disease

2.75

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.